Strategic partnering to bring cardiovascular treatment to patients around the world
Passionate about partnering, Amarin works collaboratively with strategic partners worldwide to maximise the value for patients. We have transitioned to a globally partned business model designed to maximize the value of our franchise asset, VASCEPA® / VAZKEPA® (icosapent ethyl), through strategic collaborations worldwide. Amarin prioritizes alliances with established global partners that bring deep market expertise, scale, and execution capability, while allowing Amarin to retain long-term product value through supply, and milestone-based economics. At Amarin, we believe in taking decisive steps to help patients globally, and that by joining with others we can reach our goals faster. Building alliances with complementary partners underlies our accomplishments to date and will help enhance our future successes.
Amarin has a network of experienced commercial partners for our product in focused geographies around the world where we do not have our own commercial teams. Our important prescription drug is currently marketed and sold through a syndicate of seven commercial partners in numerous key markets throughout the world with submissions seeking approval under regulatory reviews in numerous other countries. Learn more about our trusted strategic partners below.
Our trusted strategic partners
Why Partner with Amarin?
- A first-in-class therapy in VASCEPA® / VAZKEPA®, supported by robust clinical evidence and approved by multiple regulatory authorities worldwide — providing partners with a differentiated, science-led brand and a strong foundation for long-term value creation.
- Track record of successful collaboration with medical, scientific, and academic leaders, institutions, and companies throughout the world.
- Broad success in securing both pricing and government reimbursement globally, as well as payer coverage through managed care in the United States.
- Dedicated, professional Alliance Management team, and core cross-functional capabilities to support our partners across all phases of the partnership.
- Positive reputation for integrity, follow-through, and innovation.
Coming together for cardiovascular care
Want to know more about how great partnerships in cardiometabolic care is built? Read below for press releases, articles and more relating to our business associates.
Partnering Opportunities
Companies that align with Amarin's goals are encouraged to consider providing capabilities and proposals. If you are an innovative high-quality company that would like to partner with us, reach out to our business development team to learn more about current partnerships and opportunities to work with Amarin.
